DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- Revenue, 2025
- $2.0M
- YoY, 2025
- −67.3%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $2.0M | −67.3% |
| 2024 | $6.2M | +120.6% |
| 2023 | $2.8M | — |
| 2019 | $0 | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| 2016 | $0 | — |